In our present study, the lack of a general effect of TDP-43 on hypometabolic subtype is further substantiated by a complementary group comparison showing no evidence for subtype differences between pathology-confirmed AD cases with (AD + TDP-43) and without TDP-43 pathology. This evidence concerns the gene TARDBP and Alzheimer disease.